Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
xCELLigence System for Antibiotics Selection in Periodontitis
NCT03863249Phase 4Completed
- Sponsor
- UVEG
- Start
- Feb 2019
- Primary completion
- May 2022
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic periodontitis (3 arms), sponsored by UVEG. Primary endpoints: Clinical Attachment Loss change at 60 days, Probing Pocket Depth change at 60 days and 2 more. Started Feb 2019; status: completed.
02
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT03863249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03863249.